Filing Flows › Comparisons › FBIO vs DERM
Fortress Biotech vs Journey Medical: FBIO and DERM compared
Fortress Biotech is the larger company: $18.7M of revenue in its latest quarter (Q2 2026) against $18.5M for Journey Medical (Q2 2026). Journey Medical is growing faster (+23% against +14% a year earlier). Journey Medical is more profitable, with an operating margin of 2.5% against -53.5%.
Where the money goes: FBIO and DERM
Fortress Biotech (FBIO) · Q2 2026
Fortress Biotech, Q2 2026: revenue $18.7M (+14% year over year), operating margin -53.5%, net earnings $602K, operating cash flow −$59.3M. The chart follows the revenue to costs, profit and cash.
Journey Medical (DERM) · Q2 2026
Journey Medical, Q2 2026: revenue $18.5M (+23% year over year), operating margin 2.5%, net loss $312K, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.
| Fortress Biotech (FBIO) | Journey Medical (DERM) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $18.7M | $18.5M |
| Revenue growth, Y/Y | +14% | +23% |
| Operating margin | -53.5% | 2.5% |
| Net earnings | $602K | −$312K |
| Net margin | 3.2% | -1.7% |
| Operating cash flow | −$59.3M | −$1.7M |
Where the revenue comes from
Fortress Biotech
- Journey: $18.5M (99%)
- Fortress: $208K (1%)
Journey Medical
- Emrosi: $8.1M (44%)
- Qbrexza: $5.1M (28%)
- Accutane: $3.4M (18%)
- Foam franchise products (Amzeeq & Zilxi): $941K (5%)
Questions
Which is bigger, Fortress Biotech or Journey Medical?
Fortress Biotech is the larger company: $18.7M of revenue in its latest quarter (Q2 2026) against $18.5M for Journey Medical (Q2 2026).
Is Fortress Biotech or Journey Medical growing faster?
Journey Medical is growing faster (+23% against +14% a year earlier).
Which is more profitable, Fortress Biotech or Journey Medical?
Journey Medical is more profitable, with an operating margin of 2.5% against -53.5%.
More: Fortress Biotech earnings · how Fortress Biotech makes money · Journey Medical earnings · how Journey Medical makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Aug 12, 2026). Fiscal quarters can end on different dates. Not investment advice.